Share Ellen J Scherl, MD - High Hopes for Emerging Small Molecules: Looking Ahead to Expanded Treatment Options for Moderate-to-Severe Crohn's Disease

Copy link

January 04, 2023

Ellen J Scherl, MD - High Hopes for Emerging Small Molecules: Looking Ahead to Expanded Treatment Options for Moderate-to-Severe Crohn's Disease

12 minutes

Please visit answersincme.com/DRN860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in gastroenterology discusses emerging small molecule therapies in the treatment of moderate-to-severe Crohn’s disease. Upon completion of this activity, participants should be better able to: Identify the clinical rationale for using emerging selective Janus kinase (JAK) inhibitors and sphingosine 1–phosphate (S1P) receptor modulators in Crohn’s disease; Describe evidence from late-stage clinical trials on the use of small molecule therapies in individuals with moderate-to-severe Crohn’s disease; and Outline patient-centered strategies for optimizing treatment with small molecule therapies in moderate-to-severe Crohn’s disease.

...more